Piper Jaffray believes there is much misunderstanding about Aetna's policy bulletin on Questcor's Acthar and recommends using the pullback in shares as a buying opportunity. Piper does not believe Aetna’s statement signals a major change in how Acthar will be covered and reiterates an Overweight rating on Questcor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.